EMCOA
Everest Metals Corporation Ltd
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Everest Metals Corporation Ltd - Option Expiring 31-Oct-2023
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EMCOA
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in EMCOA
N/A
EMCOA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in EMCOA also invest in...
Want more shares? Try these...
Emyria Ltd. is a healthcare technology and services company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2020-02-12. The firm is focused on accelerating drug development and improving patient outcomes in neuroscience and mental health through its drug development, new drug discovery, and proprietary real-world data (RWD). The company applies in-house drug development expertise, and proprietary real-world evidence (RWE) gathered from its clinical service, to accelerate the development and registration of two biopharmaceutical drug classes: Ultra-Pure cannabidiol-based medical treatments (CBMTs) and MDMA (ecstasy) analogues. Its CBMT development program leverages the proprietary RWE to identify specific dose responses, for specific indications, in specific patient populations. Its EMD-RX5 is a novel, capsule formulation of Ultra-Pure, synthetic cannabidiol to support its registration as an over-the-counter treatment for mild stress and anxiety in patients with chronic pain. The company is also advancing Ultra-Pure CBD (EMD-RX7).
📊 Share price
$0.14 AUD
Everest Metals Corp. Ltd. engages in the exploration of economic deposits containing cobalt. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-10-18. The company has precious metal, battery metal, and critical mineral projects in Australia. Its projects include Revere Gold Project, Mt Edon Project, Ninghan Project, Rover Project, Mt Dimer Gold & Silver Project, Yarbu Gold Project and NSW Broken Hill Projects. Revere Gold Project is located along an inferred extension of the Andy Well Greenstone Shear System, with the DeGrussa Copper-Gold mine along the strike, approximately 55 kilometers (km) to the north-east. Mt Edon Project is located in the southern portion of the Paynes Find Greenstone Belt, an area known to host swarms of Pegmatites and prospective for critical metals. Ninghan Project sits in Ninghan Fold Belt mafic and ultramafic greenstone with the tenement package covering an area of approximately 228 square kilometers. The Rover Project is a tenement holding in Central Yilgarn.
📊 Share price